For patients who rely on monoclonal antibodies and other biologic drugs, treatment often means hours tethered to an IV pole ...

In this fascinating video, we dive into the incredible challenge of breath-holding. Join us as we explore techniques used by professionals to extend their breath-holding duration. Whether you are a ...

Global pharma major Lupin Limited (Lupin), announced that the United States Food and Drug Administration (FDA) has approved Armlupeg (pegfilgrastim-unne) 6 mg/0.6 mL injection for subcutaneous use in ...

Voyxact, an APRIL inhibitor, receives FDA accelerated approval for adults with primary IgA nephropathy to reduce proteinuria.

Antibody treatments for cancer and other diseases are typically delivered intravenously, because of the large volumes that are needed per dose. This means the patient has to go to a hospital for every ...

A marine bacterium that selectively targets tumor cells with minimal systemic toxicity could represent the next big thing in cancer immunotherapy. A naturally occurring, non-engineered bacterium could ...